查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855811

2025年全球癌细胞分析市场报告

Cancer Cell Analysis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，癌细胞分析市场呈现强劲成长势头，预计将从2024年的104.4亿美元成长到2025年的114.1亿美元，复合年增长率达9.3%。这一增长主要受以下因素驱动：癌症发病率上升、政府加大对癌症研究的津贴、研究机构与生物技术公司合作加强、对液态切片和其他非侵入性检测方法的需求不断增长，以及对个性化癌症治疗的需求日益增长。

预计未来几年，癌细胞分析市场将维持强劲成长，2029年市场规模将达到160.9亿美元，复合年增长率（CAGR）为9.0%。预测期内的成长预计将受到以下因素的驱动：对高通量分析技术的需求不断增长、对早期检测和筛检的重视、对单细胞和稀有细胞研究的日益关注、对精准临床决策支援的需求不断增长，以及数位病理平台的广泛应用。预测期内的主要趋势包括：人工智慧在癌细胞成像和分析中的应用、次世代定序平台的进步、多重生物标记检测方法的应用、免疫肿瘤学研究工具的进步，以及生物资讯学和巨量资料分析在实现个人化治疗方面的日益普及。

癌细胞分析是利用实验室和成像技术对癌细胞进行全面研究，以了解其结构、行为和基因特征。其主要目标是帮助癌症患者早期发现、准确诊断并制定个人化治疗方案。此外，它还有助于研究肿瘤进展、评估治疗效果、识别生物标记以及开发新的治疗方法，从而推进精准肿瘤学的发展并改善患者预后。

癌细胞分析市场的主要产品和服务包括试剂和耗材、仪器、配件、软体和服务。试剂和耗材包含用于准确检测和分析癌细胞的化学物质和生物材料。分析类型包括基因组学、蛋白质组学、代谢体学、转录组学和组织病理学。关键技术包括次世代定序仪(NGS)、聚合酵素链锁反应(PCR)、质谱分析、流式细胞技术和免疫组织化学 (IHC)。应用领域涵盖生物标记发现、药物研发、精准医疗、临床诊断和研究活动。最终用户包括製药和生物技术公司、医院和临床实验室以及学术和研究机构。

美国关税的迅速上涨以及由此引发的贸易摩擦（始于2025年春季）对医疗设备行业产生了重大影响，尤其是进口诊断成像设备部件、手术用不銹钢和塑料耗材。医院和诊所抵制价格上涨，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供癌细胞分析市场统计数据，例如全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商机，以及您在癌细胞分析行业取得成功所需的各种数据。本癌细胞分析市场研究报告全面概​​述了您所需的一切信息，并对行业现状和未来发展趋势进行了详细分析。

预计未来几年，癌症研究投入的不断增加将推动癌细胞分析市场的成长。随着全球癌症负担持续加重，各国政府和私人机构正增加对癌症研究的投入，旨在改善诊断方法并开发有效的治疗方法。癌细胞分析对癌症研究至关重要，因为它能够提供肿瘤生物学、异质性和进展的详细信息，使研究人员能够识别新的生物标记、评估治疗反应并设计标靶治疗。例如，美国国家癌症研究所（NCI）报告称，其2024财年的癌症研究预算为72亿美元，比上年度增长1.7%。这很可能导致癌症研究投入的增加，并推高对癌细胞分析技术的需求。

癌症细胞分析市场的主要企业正致力于稀有细胞和循环性肿瘤细胞(CTC) 富集等创新技术，以推进癌症研究和诊断能力。稀有细胞和 CTC 富集技术能够从血液样本中分离并捕获极低频率的癌细胞，从而提供有关肿瘤异质性、疾病进展和治疗反应的关键资讯。例如，2024 年 6 月，总部位于美国的生命科学研究和临床诊断公司 Bio-Rad Laboratories 推出了 Celselect Slides 2.0，这是一种先进的微流体晶片技术，旨在透过其 Genesis 细胞分离系统提高稀有细胞和 CTC 的捕获效率。最新版本将微腔数量从 56,400 个增加到 140,800 个，使每个晶片的样本容量提高了 2.5 倍。此外，它还能无缝整合到现有工作流程中，无需进行重大调整，从而促进癌症研究并提高细胞分析效率。

2022年2月，美国诊断和医疗保健公司LabCorp以5.75亿美元收购了Personal Genome Diagnostics Inc.。此次收购旨在透过整合PGDx全面的液态切片和基于组织的癌细胞分析技术，增强LabCorp在肿瘤学和癌症基因组学领域的实力。总部位于美国的Personal Genome Diagnostics Inc.专注于癌细胞分析和基因组学，为精准肿瘤学和临床决策支援提供先进的诊断解决方案。

研究市场包括提供咨询和研究支援服务、数据分析和生物资讯服务、药物筛检和疗效测试、组织病理学和数位病理学服务以及临床试验支援服务等服务的营业单位所获得的收入。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。癌细胞分析市场还包括数位病理扫描仪、微流体装置、液态切片套件和免疫组织化学 (IHC)套件的销售。该市场的价值为“出厂价”，即商品製造商或创造者销售的商​​品价值，无论销售对像是其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球癌细胞分析：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球癌细胞分析市场：成长率分析
  • 全球癌细胞分析市场表现：规模与成长，2019-2024年
  • 全球癌细胞分析市场预测：规模与成长，2024-2029年，2034年预测
  • 全球癌细胞分析：潜在市场规模（TAM）

第六章 市场细分

  • 全球癌细胞分析市场依产品/服务、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 试剂和耗材
  • 装置
  • 配件
  • 软体
  • 服务
  • 全球癌细胞分析市场按类型、表现和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 基因组分析
  • 蛋白质体学分析
  • 代谢组学分析
  • 转录组分析
  • 组织病理学分析
  • 全球癌细胞分析市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 次世代定序仪（NGS）
  • 聚合酵素链锁反应（PCR）
  • 质谱分析
  • 流式细胞技术
  • 免疫组织化学（IHC）
  • 全球癌细胞分析市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 生物标记发现
  • 药物开发与发现
  • 精准医疗
  • 临床诊断
  • 研究与开发
  • 全球癌细胞分析市场：依最终用途划分，实际结果与预测，2019-2024年、2024-2029年预测、2034年预测
  • 製药和生物技术公司
  • 医院和临床实验室
  • 学术研究机构
  • 其他最终用途
  • 全球癌细胞分析市场：按试剂和耗材、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 细胞培养基
  • 抗体
  • 染色和染料
  • 酵素试剂套件
  • 缓衝液和溶液
  • 全球癌细胞分析市场：依仪器、类型、表现和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 流式细胞仪
  • 显微镜
  • 细胞分析仪
  • 自动细胞计数器
  • 影像系统
  • 全球癌细胞分析市场：依配件、类型、实际结果及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 移液管和吸头
  • 培养皿和培养瓶
  • 微孔盘
  • 过滤单元
  • 样品管
  • 全球癌细胞分析市场：依软体、类型、实际数据和预测数据细分，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 数据分析软体
  • 影像分析软体
  • 测试资讯管理系统
  • 视觉化工具
  • 量化软体
  • 全球癌细胞分析市场：按服务、类型、表现和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 技术支援服务
  • 安装和维护服务
  • 校对服务
  • 培训和教育服务
  • 咨询服务

第七章 区域和国家分析

  • 全球癌细胞分析市场：依地区划分，结果及预测，2019-2024年、2024-2029年预测、2034年预测
  • 全球癌细胞分析市场：按国家、绩效和预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 癌细胞分析市场：竞争格局
  • 癌细胞分析市场：公司概况
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Merck KGaA
  • GE Healthcare Technologies Inc.
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • Olympus Corporation
  • Illumina Inc.
  • Sartorius AG
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Bruker Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Miltenyi Biotec BV & Co. KG
  • Abcam plc

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年癌细胞分析市场：提供新机会的国家
  • 2029年癌细胞分析市场：新兴细分市场带来新机会
  • 2029年癌细胞分析市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38460

Cancer cell analysis is the comprehensive examination of cancer cells using laboratory and imaging techniques to understand their structure, behavior, and genetic profile. Its primary purpose is to support early detection, accurate diagnosis, and personalized treatment strategies for cancer patients. It also enables the study of tumor progression, evaluation of treatment responses, identification of biomarkers, and development of new therapies, thereby advancing precision oncology and improving patient outcomes.

The primary products and services in the cancer cell analysis market include reagents and consumables, instruments, accessories, software, and services. Reagents and consumables consist of essential chemical and biological materials used to detect and analyze cancer cells with accuracy. The types of analysis include genomic, proteomic, metabolomic, transcriptomic, and histopathological studies. Key technologies involve next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, flow cytometry, and immunohistochemistry (IHC). Applications cover biomarker discovery, drug development, precision medicine, clinical diagnosis, and research activities. End-users include pharmaceutical and biotechnology companies, hospitals and clinical laboratories, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cancer cell analysis market research report is one of a series of new reports from The Business Research Company that provides cancer cell analysis market statistics, including cancer cell analysis industry global market size, regional shares, competitors with a cancer cell analysis market share, detailed cancer cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the cancer cell analysis industry. The cancer cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer cell analysis market size has grown strongly in recent years. It will grow from $10.44 billion in 2024 to $11.41 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. Growth in the historic period was driven by the rising prevalence of cancer, increased government funding for cancer research, stronger collaboration between research institutions and biotechnology companies, growing demand for liquid biopsy and other non-invasive testing methods, and the increasing need for personalized cancer therapies.

The cancer cell analysis market size is expected to see strong growth in the next few years. It will grow to $16.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. Growth in the forecast period is expected to be supported by rising demand for high-throughput analysis techniques, greater emphasis on early detection and screening, increasing focus on single-cell and rare cell studies, higher need for accurate clinical decision support, and wider adoption of digital pathology platforms. Key trends anticipated for the forecast period include the integration of AI in cancer cell imaging and analysis, advancements in next-generation sequencing platforms, adoption of multiplex biomarker detection assays, progress in immuno-oncology research tools, and greater use of bioinformatics and big data analytics to enable personalized therapy.

The increasing investments in cancer research are expected to propel the growth of the cancer cell analysis market in the coming years. As the global burden of cancer continues to rise, governments and private organizations are investing more funds into studies aimed at enhancing diagnostic methods and developing effective treatments. Cancer cell analysis is crucial to cancer research as it provides detailed insights into tumor biology, heterogeneity, and progression, allowing researchers to identify new biomarkers, evaluate treatment responses, and design targeted therapies. For example, the National Cancer Institute, a U.S.-based government agency, reported that the cancer research budget for the fiscal year 2024 was $7.2 billion, marking a 1.7% increase from the previous year. Therefore, the rising investments in cancer research will fuel the demand for cancer cell analysis technologies.

Key players in the cancer cell analysis market are focusing on innovations such as rare cell and circulating tumor cell (CTC) enrichment technologies to enhance cancer research and diagnostic capabilities. Rare cell and CTC enrichment involves isolating and capturing extremely low-frequency tumor cells from blood samples, which provide vital information about tumor heterogeneity, disease progression, and treatment responses. For example, in June 2024, Bio-Rad Laboratories Inc., a life science research and clinical diagnostics company based in the U.S., introduced Celselect Slides 2.0, an advanced microfluidic slide technology designed to improve rare cell and CTC capture with its Genesis Cell Isolation System. The updated version allows for 2.5 times more sample capacity per slide by increasing microchambers from 56,400 to 140,800. It also integrates seamlessly into existing workflows, boosting cancer research and enhancing the efficiency of cell analysis without requiring significant adjustments.

In February 2022, Labcorp, a U.S.-based diagnostics and healthcare company, acquired Personal Genome Diagnostics Inc. for $575 million. This acquisition is aimed at strengthening Labcorp's oncology and cancer genomics portfolio by incorporating PGDx's comprehensive liquid biopsy and tissue-based cancer cell analysis technologies. Personal Genome Diagnostics Inc., a U.S.-based company specializing in cancer cell analysis and genomics, offers advanced diagnostic solutions that support precision oncology and clinical decision-making.

Major players in the cancer cell analysis market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Olympus Corporation, Illumina Inc., Sartorius AG, PerkinElmer Inc., Sysmex Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Miltenyi Biotec B.V. & Co. KG, Abcam plc, Promega Corporation, Creative Bioarray Inc., NanoCellect Biomedical Inc., Cell Biolabs Inc., Meiji Techno Co. Ltd.

North America was the largest region in the cancer cell analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer cell analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer cell analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer cell analysis market includes revenues earned by entities by providing services such as consulting and research support services, data analysis and bioinformatics services, drug screening and efficacy testing, histopathology and digital pathology services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cancer cell analysis market also includes sales of digital pathology scanners, microfluidic devices, liquid biopsy kits, and immunohistochemistry (IHC) kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Cell Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer cell analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer cell analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer cell analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Reagents And Consumables; Instruments; Accessories; Software; Service
  • 2) By Type Of Analysis: Genomic Analysis; Proteomic Analysis; Metabolomic Analysis; Transcriptomic Analysis; Histopathological Analysis
  • 3) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Mass Spectrometry; Flow Cytometry; Immunohistochemistry (IHC)
  • 4) By Application: Biomarker Discovery; Drug Development And Discovery; Precision Medicine; Clinical Diagnosis; Research And Development
  • 5) By End-Use: Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Testing Laboratories; Academic And Research Institutes; Other End-Uses
  • Subsegments:
  • 1) By Reagents And Consumables: Cell Culture Media; Antibodies; Stains And Dyes; Enzyme Kits; Buffers And Solutions
  • 2) By Instruments: Flow Cytometers; Microscopes; Cell Analyzers; Automated Cell Counters; Imaging Systems
  • 3) By Accessories: Pipettes And Tips; Culture Plates And Flasks; Microplates; Filtration Units; Sample Tubes
  • 4) By Software: Data Analysis Software; Image Analysis Software; Laboratory Information Management Systems; Visualization Tools; Quantification Software
  • 5) By Service: Technical Support Services; Installation And Maintenance Services; Calibration Services; Training And Education Services; Consultation Services
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Merck KGaA; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Olympus Corporation; Illumina Inc.; Sartorius AG; PerkinElmer Inc.; Sysmex Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Miltenyi Biotec B.V. & Co. KG; Abcam plc; Promega Corporation; Creative Bioarray Inc.; NanoCellect Biomedical Inc.; Cell Biolabs Inc.; Meiji Techno Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Cell Analysis Market Characteristics

3. Cancer Cell Analysis Market Trends And Strategies

4. Cancer Cell Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Cell Analysis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Cell Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Cell Analysis Market Growth Rate Analysis
  • 5.4. Global Cancer Cell Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Cell Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Cell Analysis Total Addressable Market (TAM)

6. Cancer Cell Analysis Market Segmentation

  • 6.1. Global Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Accessories
  • Software
  • Service
  • 6.2. Global Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomic Analysis
  • Proteomic Analysis
  • Metabolomic Analysis
  • Transcriptomic Analysis
  • Histopathological Analysis
  • 6.3. Global Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Mass Spectrometry
  • Flow Cytometry
  • Immunohistochemistry (IHC)
  • 6.4. Global Cancer Cell Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biomarker Discovery
  • Drug Development And Discovery
  • Precision Medicine
  • Clinical Diagnosis
  • Research And Development
  • 6.5. Global Cancer Cell Analysis Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinical Testing Laboratories
  • Academic And Research Institutes
  • Other End-Uses
  • 6.6. Global Cancer Cell Analysis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Media
  • Antibodies
  • Stains And Dyes
  • Enzyme Kits
  • Buffers And Solutions
  • 6.7. Global Cancer Cell Analysis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flow Cytometers
  • Microscopes
  • Cell Analyzers
  • Automated Cell Counters
  • Imaging Systems
  • 6.8. Global Cancer Cell Analysis Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pipettes And Tips
  • Culture Plates And Flasks
  • Microplates
  • Filtration Units
  • Sample Tubes
  • 6.9. Global Cancer Cell Analysis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Image Analysis Software
  • Laboratory Information Management Systems
  • Visualization Tools
  • Quantification Software
  • 6.10. Global Cancer Cell Analysis Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technical Support Services
  • Installation And Maintenance Services
  • Calibration Services
  • Training And Education Services
  • Consultation Services

7. Cancer Cell Analysis Market Regional And Country Analysis

  • 7.1. Global Cancer Cell Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Cell Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Cell Analysis Market

  • 8.1. Asia-Pacific Cancer Cell Analysis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Cell Analysis Market

  • 9.1. China Cancer Cell Analysis Market Overview
  • 9.2. China Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Cell Analysis Market

  • 10.1. India Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Cell Analysis Market

  • 11.1. Japan Cancer Cell Analysis Market Overview
  • 11.2. Japan Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Cell Analysis Market

  • 12.1. Australia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Cell Analysis Market

  • 13.1. Indonesia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Cell Analysis Market

  • 14.1. South Korea Cancer Cell Analysis Market Overview
  • 14.2. South Korea Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Cell Analysis Market

  • 15.1. Western Europe Cancer Cell Analysis Market Overview
  • 15.2. Western Europe Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Cell Analysis Market

  • 16.1. UK Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Cell Analysis Market

  • 17.1. Germany Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Cell Analysis Market

  • 18.1. France Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Cell Analysis Market

  • 19.1. Italy Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Cell Analysis Market

  • 20.1. Spain Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Cell Analysis Market

  • 21.1. Eastern Europe Cancer Cell Analysis Market Overview
  • 21.2. Eastern Europe Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Cell Analysis Market

  • 22.1. Russia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Cell Analysis Market

  • 23.1. North America Cancer Cell Analysis Market Overview
  • 23.2. North America Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Cell Analysis Market

  • 24.1. USA Cancer Cell Analysis Market Overview
  • 24.2. USA Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Cell Analysis Market

  • 25.1. Canada Cancer Cell Analysis Market Overview
  • 25.2. Canada Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Cell Analysis Market

  • 26.1. South America Cancer Cell Analysis Market Overview
  • 26.2. South America Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Cell Analysis Market

  • 27.1. Brazil Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Cell Analysis Market

  • 28.1. Middle East Cancer Cell Analysis Market Overview
  • 28.2. Middle East Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Cell Analysis Market

  • 29.1. Africa Cancer Cell Analysis Market Overview
  • 29.2. Africa Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Cell Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Cell Analysis Market Competitive Landscape
  • 30.2. Cancer Cell Analysis Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Cell Analysis Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. GE Healthcare Technologies Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Agilent Technologies Inc.
  • 31.5. Olympus Corporation
  • 31.6. Illumina Inc.
  • 31.7. Sartorius AG
  • 31.8. PerkinElmer Inc.
  • 31.9. Sysmex Corporation
  • 31.10. Bruker Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. QIAGEN N.V.
  • 31.13. Tecan Group Ltd.
  • 31.14. Miltenyi Biotec B.V. & Co. KG
  • 31.15. Abcam plc

32. Global Cancer Cell Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Cell Analysis Market

34. Recent Developments In The Cancer Cell Analysis Market

35. Cancer Cell Analysis Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Cell Analysis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Cell Analysis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Cell Analysis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer